Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study
OTC drug use is common among people with migraine; however, it is not frequently discussed with doctors. Many respondents, even those with frequent OTC drug use, did not have access or awareness of migraine-specific drugs. To prevent medication overuse for migraine, the use of OTC drugs should also be discussed and managed.
Authors
- Tsubasa Takizawa (ORCID: https://orcid.org/0000-0003-2605-7200)
- Chie Hashimoto (ORCID: https://orcid.org/0000-0003-3668-3256)
- Daisuke Danno (ORCID: https://orcid.org/0000-0003-3737-4754)
- Yoshinori Tanizawa (ORCID: https://orcid.org/0000-0002-5014-2483)
- Mika Komori (ORCID: https://orcid.org/0000-0003-1887-1296)
- Satoshi Osaga (ORCID: https://orcid.org/0000-0003-4459-2469)
- Ryotaro Ishii (ORCID: https://orcid.org/0000-0002-6976-1081)
- Shiho Suzuki (ORCID: https://orcid.org/0009-0007-7430-2078)
- Moemi Miura (ORCID: https://orcid.org/0009-0007-8632-9294)
Institutions
- Keio University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Tominaga hospital (JP)
- Eli Lilly (Japan) (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1186/s10194-025-02046-8
- Citations
- 4
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- Eli Lilly and Company
- Eli Lilly Japan